Music Legend Natalie Cole, R&B Icon Maxine Nightingale and Other Luminaries to Join Tower Cancer Research Foundation in Honoring Julian Gold, M.D., Beverly Hills Vice-Mayor and Randall Katz, CEO, Milestone Entertainment on May 7, 2014
Music Legend Natalie Cole, R&B Icon Maxine Nightingale and Other Luminaries to Join Tower Cancer Research Foundation in Honoring Julian Gold, M.D., Beverly Hills Vice-Mayor and Randall Katz, CEO, Milestone Entertainment on May 7, 2014
LOS ANGELES, May 1, 2014 /PRNewswire/ -- Music legend Natalie Cole and leaders in entertainment, politics, business and medicine will come together at Tower Cancer Research Foundation's (TCRF) Tower of Hope Gala on Wednesday, May 7, 2014 to honor Beverly Hills Vice-Mayor Julian A. Gold, M.D. and Randall (Randy) Katz, CEO of Milestone Entertainment. The event will begin at 5:30 PM at the Beverly Hilton Hotel, 9876 Wilshire Boulevard in Beverly Hills, California. R&B music icon Maxine Nightingale will perform. Gold is the Co-Chairman of the Department of Anesthesiology at Cedars-Sinai Medical Center. Katz is a TCRF Board member and Chair of the UCLA Jonsson Cancer Center Foundation Board. The evening is designed to bring attention to and raise funding for TCRF, a boutique donor-directed cancer research foundation. TCRF seeks to accelerate the development of cancer treatments, improve patient access to new agents and methodologies, and provide support and educational programs for patients and their families.
Logo - http://photos.prnewswire.com/prnh/20140501/82936
Guests will learn how TCRF has been the Southern California cancer patient's greatest ally since 1996. TCRF is known for its stellar reputation professionally vetting cancer research programs and maximizing the impact of donor-investors. The foundation, which is focused on Southern California, provides grants for clinical trials, innovative cancer research, caring patient support and community education. In line with its mission to advance cancer research on every level, TCRF supports pioneering and talented physician scientists with awards of annual grants to those doing cutting edge bench-to-bedside lab research. TCRF's patient support services include patient mentoring, cancer support groups, free workshops and support for caregivers. TCRF's Free Cancer Information and Resource Telephone Help Line, staffed by professional social workers, is designed to help cancer patients and their families cope with the complexities and challenges of a cancer diagnosis and cancer treatment.
TCRF's demonstrated commitment to both the Southern California community and to nurturing local cancer research talent inspired Gold and Katz to step forward as this year's honorees. For tickets, contact (310) 288-1755 or visit www.towercancer.org
ABOUT TOWER CANCER RESEARCH FOUNDATION ?Founded in 1996 and primarily focused on Southern California, TCRF provides grants for clinical trials, innovative research, caring patient support and community education to promote more effective treatments for cancer and blood disorders. As a leading boutique cancer research foundation in Southern California, TCRF has raised over $25 million in the last decade. These resources, which are donor directed, have funded specific programs that are professionally vetted by committees comprised of local scientific and community leaders. In addition, TCRF awards $100,000 in grants annually to young pioneering physician scientists engaged in groundbreaking bench-to-bedside research. While there are many brilliant scientists performing cancer research, TCRF recognizes the importance of nurturing the local pool of rich research talent because important breakthroughs have come from unexpected directions and provided new perspectives. www.towercancer.org
Contact: Rachel Schwartz/PR AdvantEDGE, Inc.
310.990.2764
Read more news from Tower Cancer Research Foundation.
SOURCE Tower Cancer Research Foundation
Photo:http://photos.prnewswire.com/prnh/20140501/82936
http://photoarchive.ap.org/
Tower Cancer Research Foundation
Web Site: http://www.towercancer.org
-------
Profile: intent
0 Comments:
Post a Comment
<< Home